Halyard Purple Nitrile-XTRA* Powder-Free Exam Gloves, Low Dermatitis Potential, Tested for Use with Chemotherapy Drugs, Fentanyl Citrate and Fentanyl Citrate in Simulated Gastric Acid

Halyard Purple Nitrile-XTRA* Powder-Free Exam Gloves, Low Dermatitis Potential, Tested for Use with Chemotherapy Drugs, Fentanyl Citrate and Fentanyl Citrate in Simulated Gastric Acid are disposable devices intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner.

The following chemotherapy drugs and concentration had NO breakthrough detected up to 240 minutes:

Arsenic Trioxide (1 mg/ml)

Bendamustine, (5 mg/ml)

Blenoxane (15 mg/ml)

Bleomycin (15 mg/ml)

Bortezomib (1 mg/ml)

Busulfan (6 mg/ml)

Carboplatln (10 mg/ml)

Carfilzomib (2 mg/ml)

Cetuximab (2 mg/ml)

Cisplatin (1 mg/ml)

Cyclophosphamide (Cytoxan) (20 mg/ml)

Cytarabine (100 mg/ml)

Dacarbazine (DTIC) {10 mg/ml)

Daunorubicin {5 mg/ml)

Decitabine (5 mg/ml)

Docetaxel (10 mg/ml)

Doxorubicin HCL (2 mg/ml)

Ellence (2 mg/ml)

Erbitux (2 mg/ml)

Eribilin Mesylate (0.5 mg/ml)

Etoposide (Toposar) (20 mg/ml)

Fludarabine (25 mg/ml)

Fulvestrant (50 mg/ml)

Gemcitabine (Gemzar) (38 mg/ml)

ldarubicin (1 mg/ml)

Ifosfamide (IFEX) (50 mg/ml)

Irinotecan (20 mg/ml)

Mechlorethamine HCL (1 mg/ml)

Melphalan (5 mg/ml)

Methotrexate (25 mg/ml)

Mitomycin C (0.5 mg/ml)

Mitoxantrone (2 mg/ml)

Oxaliplatin (2 mg/ml)

Paclitaxel (Taxol) (6 mg/ml)

Paraplatin (10 mg/ml)

Pemetrexed Disodium (25 mg/ml)

Pertuzumab (30 mg/ml)

Raltitrexed (0.5 mg/ml)

Rituximab (Rituxan) (10 mg/ml)

Temsirolimus (25 mg/ml)

Thiotepa (10 mg/ml)

Topotecan HCL (1 mg/ml)

Trastuzumab (21 mg/ml)

Trisenox (1 mg/ml)

Velcade (1 mg/ml)

Vinblastine (1 mg/ml)

Vinorelbine (10 mg/ml)

Carmustine (3.3 mg/ml) permeation occurred at 60.0 minutes.

The following hazardous drugs (opioids) and concentration had NO breakthrough detected up to 240 minutes:

Fentanyl Citrate Injection (100 mcg/2 ml)

Gastric Acid Fluid/Fentanyl Citrate Injection Mix (50/50 Solution)

Caution: Testing showed a minimum breakthrough time of 60.0 minutes with Carmustine.

The following hazardous drugs and concentration had NO breakthrough detected up to 240 minutes:

Cytovene (10 mg/ml)

Retrovir (10 mg/ml)

Triclosan (2 mg/ml)

Zoledronic Acid (0.8 mg/ml)